# Editas Medicine, Inc. (EDIT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Editas Medicine, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/EDIT/mda/fy2025/): filed 2026-03-09; accession 0001650664-26-000017 (https://www.sec.gov/Archives/edgar/data/1650664/000165066426000017/edit-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/EDIT/mda/fy2024/): filed 2025-03-05; accession 0001650664-25-000022 (https://www.sec.gov/Archives/edgar/data/1650664/000165066425000022/edit-20241231.htm)
- [FY 2023 MD&A](/company/EDIT/mda/fy2023/): filed 2024-02-28; accession 0001650664-24-000008 (https://www.sec.gov/Archives/edgar/data/1650664/000165066424000008/edit-20231231.htm)
- [FY 2022 MD&A](/company/EDIT/mda/fy2022/): filed 2023-02-22; accession 0001558370-23-001764 (https://www.sec.gov/Archives/edgar/data/1650664/000155837023001764/edit-20221231x10k.htm)
- [FY 2021 MD&A](/company/EDIT/mda/fy2021/): filed 2022-02-24; accession 0001558370-22-001950 (https://www.sec.gov/Archives/edgar/data/1650664/000155837022001950/edit-20211231x10k.htm)

Back to /company/EDIT/